Fibroheal intends to scale up its market, recruit more people, invest in a future robust pipeline of products
Fibroheal Woundcare has raised Rs 6.3 crore in funding from the promoters and new investors including some leading surgeons, medical professionals and bankers. Fibroheal also commits another 10 crore from existing and some new investors.
Fibroheal intends to scale up its market, recruit more people, invest in a future robust pipeline of products in the medical devices area and create an impact through the economic multiplier potential of silk and a few other biomaterials.
Co-founder of Fibroheal, Bharat Tandon who led the round said, "Congratulations to the whole team of Fibroheal on successful closure of your Pre Series A Fundraise. As the earliest backer of Fibroheal which is a pioneer in the medical application of silk proteins, I am happy to have led this round because I believe the product pipeline which the R&D team is working on is robust and extremely valuable with great potential, Good luck to the entire team."